PIII Net Income From Continuing Ops vs Selling General Administrative Analysis

PIII Stock

USD 0.21 0.01 4.55%

P3 Health financial indicator trend analysis is much more than just breaking down P3 Health Partners prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether P3 Health Partners is a good investment. Please check the relationship between P3 Health Net Income From Continuing Ops and its Selling General Administrative accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Net Income From Continuing Ops vs Selling General Administrative

Net Income From Continuing Ops vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of P3 Health Partners Net Income From Continuing Ops account and Selling General Administrative. At this time, the significance of the direction appears to have pay attention.

The correlation between P3 Health's Net Income From Continuing Ops and Selling General Administrative is -0.97. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of P3 Health Partners, assuming nothing else is changed. The correlation between historical values of P3 Health's Net Income From Continuing Ops and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of P3 Health Partners are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Net Income From Continuing Ops i.e., P3 Health's Net Income From Continuing Ops and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

-0.97

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Income From Continuing Ops

Selling General Administrative

Most indicators from P3 Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into P3 Health Partners current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

As of now, P3 Health's Tax Provision is increasing as compared to previous years. The P3 Health's current Sales General And Administrative To Revenue is estimated to increase to 0.19, while Selling General Administrative is projected to decrease to under 87.6 M.

	2020	2021	2023	2024 (projected)
Interest Expense	2.5M	11.4M	16.0M	16.8M
Depreciation And Amortization	795.2K	87.3M	86.7M	91.0M

Interest Expense Depreciation And Amortization

P3 Health fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity
Common Stock Shares Outstanding		0.25	0.57	0.59	0.6	0.36	-0.61	-0.51	0.77	-0.47	0.71	-0.79	0.23	-0.03	0.22	0.07	0.77	0.56	-0.03	0.68	0.65	0.55	0.66	-0.91	0.48	0.78
Total Assets	0.25		0.76	0.73	0.74	0.93	-0.84	-0.87	0.58	-0.73	0.17	-0.29	0.93	0.84	1.0	0.27	0.29	0.76	0.84	0.59	0.82	0.78	0.52	-0.19	0.62	0.73
Short Long Term Debt Total	0.57	0.76		1.0	1.0	0.65	-0.94	-0.96	0.8	-0.92	0.72	-0.8	0.82	0.35	0.74	0.57	0.82	1.0	0.35	0.97	0.95	1.0	0.92	-0.42	0.77	0.93
Other Current Liab	0.59	0.73	1.0		1.0	0.63	-0.94	-0.95	0.8	-0.9	0.74	-0.82	0.78	0.31	0.72	0.57	0.84	1.0	0.31	0.97	0.95	0.99	0.94	-0.45	0.75	0.93
Total Current Liabilities	0.6	0.74	1.0	1.0		0.65	-0.95	-0.95	0.81	-0.88	0.74	-0.82	0.77	0.32	0.72	0.56	0.85	0.99	0.32	0.97	0.96	0.99	0.94	-0.49	0.72	0.94
Total Stockholder Equity	0.36	0.93	0.65	0.63	0.65		-0.74	-0.74	0.71	-0.57	0.03	-0.2	0.77	0.89	0.92	-0.04	0.28	0.65	0.89	0.53	0.72	0.67	0.45	-0.35	0.58	0.68
Other Liab	-0.61	-0.84	-0.94	-0.94	-0.95	-0.74		0.99	-0.72	0.82	-0.66	0.76	-0.81	-0.43	-0.83	-0.57	-0.71	-0.94	-0.43	-0.86	-1.0	-0.94	-0.87	0.54	-0.62	-0.97
Net Tangible Assets	-0.51	-0.87	-0.96	-0.95	-0.95	-0.74	0.99		-0.69	0.86	-0.62	0.71	-0.87	-0.47	-0.86	-0.6	-0.67	-0.95	-0.47	-0.86	-0.98	-0.96	-0.85	0.43	-0.66	-0.93
Property Plant And Equipment Net	0.77	0.58	0.8	0.8	0.81	0.71	-0.72	-0.69		-0.69	0.51	-0.65	0.55	0.38	0.56	0.0	0.79	0.78	0.38	0.86	0.75	0.78	0.75	-0.65	0.77	0.81
Current Deferred Revenue	-0.47	-0.73	-0.92	-0.9	-0.88	-0.57	0.82	0.86	-0.69		-0.65	0.7	-0.9	-0.39	-0.71	-0.49	-0.65	-0.93	-0.39	-0.87	-0.85	-0.94	-0.71	0.19	-0.91	-0.82
Net Debt	0.71	0.17	0.72	0.74	0.74	0.03	-0.66	-0.62	0.51	-0.65		-0.98	0.33	-0.35	0.15	0.69	0.89	0.72	-0.35	0.81	0.69	0.7	0.84	-0.56	0.45	0.74
Retained Earnings	-0.79	-0.29	-0.8	-0.82	-0.82	-0.2	0.76	0.71	-0.65	0.7	-0.98		-0.41	0.21	-0.28	-0.62	-0.94	-0.8	0.21	-0.88	-0.79	-0.78	-0.9	0.66	-0.53	-0.84
Accounts Payable	0.23	0.93	0.82	0.78	0.77	0.77	-0.81	-0.87	0.55	-0.9	0.33	-0.41		0.71	0.92	0.41	0.35	0.83	0.71	0.66	0.82	0.85	0.53	-0.04	0.79	0.73
Cash	-0.03	0.84	0.35	0.31	0.32	0.89	-0.43	-0.47	0.38	-0.39	-0.35	0.21	0.71		0.85	-0.22	-0.16	0.35	1.0	0.17	0.41	0.38	0.04	0.05	0.46	0.33
Non Current Assets Total	0.22	1.0	0.74	0.72	0.72	0.92	-0.83	-0.86	0.56	-0.71	0.15	-0.28	0.92	0.85		0.28	0.27	0.75	0.85	0.57	0.8	0.77	0.51	-0.18	0.6	0.72
Non Currrent Assets Other	0.07	0.27	0.57	0.57	0.56	-0.04	-0.57	-0.6	0.0	-0.49	0.69	-0.62	0.41	-0.22	0.28		0.46	0.57	-0.22	0.5	0.55	0.56	0.63	-0.03	0.12	0.47
Other Assets	0.77	0.29	0.82	0.84	0.85	0.28	-0.71	-0.67	0.79	-0.65	0.89	-0.94	0.35	-0.16	0.27	0.46		0.8	-0.16	0.93	0.74	0.78	0.94	-0.67	0.56	0.8
Long Term Debt	0.56	0.76	1.0	1.0	0.99	0.65	-0.94	-0.95	0.78	-0.93	0.72	-0.8	0.83	0.35	0.75	0.57	0.8		0.35	0.96	0.95	1.0	0.9	-0.39	0.79	0.92
Cash And Short Term Investments	-0.03	0.84	0.35	0.31	0.32	0.89	-0.43	-0.47	0.38	-0.39	-0.35	0.21	0.71	1.0	0.85	-0.22	-0.16	0.35		0.17	0.41	0.38	0.04	0.05	0.46	0.33
Net Receivables	0.68	0.59	0.97	0.97	0.97	0.53	-0.86	-0.86	0.86	-0.87	0.81	-0.88	0.66	0.17	0.57	0.5	0.93	0.96	0.17		0.89	0.95	0.94	-0.52	0.77	0.9
Good Will	0.65	0.82	0.95	0.95	0.96	0.72	-1.0	-0.98	0.75	-0.85	0.69	-0.79	0.82	0.41	0.8	0.55	0.74	0.95	0.41	0.89		0.95	0.88	-0.56	0.67	0.98
Non Current Liabilities Total	0.55	0.78	1.0	0.99	0.99	0.67	-0.94	-0.96	0.78	-0.94	0.7	-0.78	0.85	0.38	0.77	0.56	0.78	1.0	0.38	0.95	0.95		0.89	-0.38	0.79	0.92
Capital Lease Obligations	0.66	0.52	0.92	0.94	0.94	0.45	-0.87	-0.85	0.75	-0.71	0.84	-0.9	0.53	0.04	0.51	0.63	0.94	0.9	0.04	0.94	0.88	0.89		-0.61	0.52	0.88
Inventory	-0.91	-0.19	-0.42	-0.45	-0.49	-0.35	0.54	0.43	-0.65	0.19	-0.56	0.66	-0.04	0.05	-0.18	-0.03	-0.67	-0.39	0.05	-0.52	-0.56	-0.38	-0.61		-0.15	-0.68
Other Current Assets	0.48	0.62	0.77	0.75	0.72	0.58	-0.62	-0.66	0.77	-0.91	0.45	-0.53	0.79	0.46	0.6	0.12	0.56	0.79	0.46	0.77	0.67	0.79	0.52	-0.15		0.68
Other Stockholder Equity	0.78	0.73	0.93	0.93	0.94	0.68	-0.97	-0.93	0.81	-0.82	0.74	-0.84	0.73	0.33	0.72	0.47	0.8	0.92	0.33	0.9	0.98	0.92	0.88	-0.68	0.68

Click cells to compare fundamentals

P3 Health Account Relationship Matchups

P3 Health fundamental ratios Accounts

		2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding		47.6M	39.5M	41.6M	41.6M	294.6M	309.3M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:

How To Invest In PIII

Details

Is PIII Stock a good investment?

Details

What is P3 Health's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.86)

Revenue Per Share

11.552

Quarterly Revenue Growth

0.152

Return On Assets

(0.12)

Return On Equity

(0.41)

The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PIII Net Income From Continuing Ops vs Selling General Administrative Analysis

Net Income From Continuing Ops vs Selling General Administrative

Net Income From Continuing Ops vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Selling General Administrative

P3 Health fundamental ratios Correlations

P3 Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

P3 Health fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Other Current Liab	+ 1.0	Short Long Term Debt Total
Total Current Liabilities	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Current Liabilities	+ 1.0	Other Current Liab

Good Will	- 1.0	Other Liab
Retained Earnings	- 0.98	Net Debt
Good Will	- 0.98	Net Tangible Assets
Other Stockholder Equity	- 0.97	Other Liab
Non Current Liabilities Total	- 0.96	Net Tangible Assets
Net Tangible Assets	- 0.96	Short Long Term Debt Total